| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Andrology, Vol 22, Issue 3 471-480, Copyright © 2001 by The American Society of Andrology
JOURNAL ARTICLE |
G. Yang, C. W. Gregory, Q. Shang, D. A. O'Brien and Y. L. Zhang
Department of Pediatrics, University of North Carolina at Chapel Hill, USA.
CCAAT/enhancer-binding protein delta (C/EBPdelta) is a nuclear transcription factor that regulates cellular growth and differentiation. In this study we demonstrate that C/EBPdelta gene expression is differentially regulated in rat androgen-dependent tissues and human prostate cancer. C/EBPdelta messenger RNA (mRNA) levels were very low in adult rat ventral prostate, epididymis, and testis. In ventral prostate and epididymis, expression of C/EBPdelta mRNA increased more than sixfold when testicular testosterone was eliminated by surgical castration or treatment with ethane-1,2-dimethanesulfonate (EDS). Testosterone replacement reduced C/EBPdelta mRNA levels to near control values in both tissues. CWR22 is a human prostate cancer xenograft that mimics biological characteristics of androgen-dependent and androgen-independent human prostate cancer. In androgen-dependent CWR22 tumors, expression of C/EBPdelta mRNA declined in response to castration. Both C/EBPdelta mRNA and protein levels increased following testosterone administration. However, C/EBPdelta mRNA and protein levels were variable in recurrent CWR22 tumors growing in the absence of testicular androgen for approximately 5 months. C/EBPdelta expression was also variable in androgen-independent human prostate carcinomas (n = 3), although mRNA levels were substantially lower than those in androgen-dependent tumors (n = 3). These studies demonstrate that androgen down-regulates C/EBPdelta levels in androgen-dependent rat tissues, but induces C/EBPdelta expression in androgen-dependent human prostate cancer. Deregulation of C/EBPdelta occurs when prostate cancer progresses to the androgen-independent state.
This article has been cited by other articles:
![]() |
A. J. Asirvatham, M. Schmidt, B. Gao, and J. Chaudhary Androgens Regulate the Immune/Inflammatory Response and Cell Survival Pathways in Rat Ventral Prostate Epithelial Cells Endocrinology, January 1, 2006; 147(1): 257 - 271. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Wang, J. T. Tseng, and W.-C. Chang Induction of Human NF-IL6{beta} by Epidermal Growth Factor Is Mediated through the p38 Signaling Pathway and cAMP Response Element-binding Protein Activation in A431 Cells Mol. Biol. Cell, July 1, 2005; 16(7): 3365 - 3376. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. V. Desai, A. M. Michalowska, P. Kondaiah, J. M. Ward, J. H. Shih, and J. E. Green Gene Expression Profiling Identifies a Unique Androgen-Mediated Inflammatory/Immune Signature and a PTEN (Phosphatase and Tensin Homolog Deleted on Chromosome 10)-Mediated Apoptotic Response Specific to the Rat Ventral Prostate Mol. Endocrinol., December 1, 2004; 18(12): 2895 - 2907. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Yang, Y.-L. Zhang, G. M. Buchold, A. M. Jetten, and D. A. O'Brien Analysis of Germ Cell Nuclear Factor Transcripts and Protein Expression During Spermatogenesis Biol Reprod, May 1, 2003; 68(5): 1620 - 1630. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Hutt and J. W. DeWille Oncostatin M Induces Growth Arrest of Mammary Epithelium via a CCAAT/enhancer-binding Protein {delta}-dependent Pathway Mol. Cancer Ther., June 1, 2002; 1(8): 601 - 610. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hsia and G. A. Cornwall CCAAT/Enhancer Binding Protein {beta} Regulates Expression of the Cystatin-Related Epididymal Spermatogenic (Cres) Gene Biol Reprod, November 1, 2001; 65(5): 1452 - 1461. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |